| 120.45 5.21 (4.52%) | 04-13 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 146 |
1-year : | 170.52 |
| Resists | First : | 125 |
Second : | 146 |
| Pivot price | 118.46 |
|||
| Supports | First : | 117.15 |
Second : | 112.3 |
| MAs | MA(5) : | 118.59 |
MA(20) : | 117.98 |
| MA(100) : | 152.02  |
MA(250) : | 153.4 |
|
| MACD | MACD : | -3.3 |
Signal : | -4.5 |
| %K %D | K(14,3) : | 41.3 |
D(3) : | 44.8 |
| RSI | RSI(14): 47.5 |
|||
| 52-week | High : | 212 | Low : | 97.16 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ IRTC ] has closed below upper band by 27.2%. Bollinger Bands are 65.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 120.51 - 121.1 | 121.1 - 121.71 |
| Low: | 113.17 - 113.77 | 113.77 - 114.38 |
| Close: | 119.45 - 120.44 | 120.44 - 121.43 |
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Fri, 10 Apr 2026
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewir - The National Law Review
Thu, 09 Apr 2026
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - Finviz
Thu, 09 Apr 2026
Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm - PR Newswire
Mon, 02 Mar 2026
How The iRhythm Holdings (IRTC) Story Is Shifting As Targets Reset And Guidance Holds - Yahoo Finance
Sun, 01 Feb 2026
iRhythm Holdings Restructures Into New Parent Company Reporting Framework - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 32 (M) |
| Shares Float | 30 (M) |
| Held by Insiders | 1.1 (%) |
| Held by Institutions | 114.2 (%) |
| Shares Short | 2,890 (K) |
| Shares Short P.Month | 3,400 (K) |
| EPS | -1.39 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.73 |
| Profit Margin | -6 % |
| Operating Margin | 4.1 % |
| Return on Assets (ttm) | -2.4 % |
| Return on Equity (ttm) | -36.6 % |
| Qtrly Rev. Growth | 27.1 % |
| Gross Profit (p.s.) | 16.31 |
| Sales Per Share | 23.11 |
| EBITDA (p.s.) | -0.95 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 81 (M) |
| Levered Free Cash Flow | 72 (M) |
| PE Ratio | -86.66 |
| PEG Ratio | 0 |
| Price to Book value | 25.46 |
| Price to Sales | 5.21 |
| Price to Cash Flow | 48.14 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|